The global cranial fixation and stabilization devices market size was valued at USD 1.69 billion in 2017. It is expected to witness a CAGR of 5.6% during the forecast period. Surging demand for minimally invasive neurosurgeries is estimated to fuel the demand for these devices in the coming years.
Rising incidence of road accidents and spiraling demand for effective reconstructive surgeries are anticipated to enable positive market growth for cranial fixation and stabilization devices. In addition, increasing incidence of brain cancer, aneurysms, and head trauma is one of the primary growth stimulants for the market. According to statistics published by the Brain Aneurysm Foundation in 2017, around 6 million population in the U.S. alone have brain aneurysm and this number is likely to increase over the forecast.
Mounting cases of spinal disorders and trauma requiring cranial fixation during surgeries is another factor propelling the market growth. Furthermore, the rising adoption of deep brain stimulation procedures is projected to stoke the growth of the market. Cranial fixation and stabilization devices assist in treating neuro-oncology, spinal disorders, dura mater repair, pelvic or trauma, neurovascular diseases, trans nasal skull-based surgery, and CSF management.
Technological advancements are paving way for novel devices, which are poised to shape the future of the market. Emerging regions offer tremendous growth potential, thanks to improving healthcare infrastructure. However, the dearth of expertise is expected to act as a stumbling stone in the development of the market.
The fixation product segment accounted for the largest revenue share in 2017. The segment is estimated to retain its position until 2025. Rising adoption of cranial fixation systems due to the high incidence of head injuries and skull fractures is the key factor contributing to the dominance of the segment. Statistics published by CDC indicate that traumatic brain injury (TBI) is one of the major causes of deaths in the U.S. In the country, every day 153 people die from injuries that include TBI.
On the other hand, the stabilization segment is anticipated to witness lucrative growth in the coming years due to the growing demand from neurosurgeons. It offers stability to the head while performing neurosurgeries. There are two types of stabilization instruments, skull clamps, and horseshoe headrest.
Based on end use, hospitals were the leading revenue contributor in the global cranial fixation and stabilization market. The segment will continue to lead the market until 2025, owing to a large number of neurosurgery performed in these facilities. Statistics published by the National Center of Biotechnology Information, around 23 to 24 million people in the world get injured due to road accidents every year, and around 200 people dies in road accidents in the U.S. alone.
This showcases the high demand for surgical procedures in hospitals in the coming years. However, the high treatment cost and maximum hospital stay in the outpatient department are some of the factors responsible for declining the share of hospital segments over the forecast period.
Ambulatory surgical centers (ACS) are expected to witness significant growth in the coming years as they offer surgical procedures at a lower cost as compared to hospitals. In addition, in 2015 the Centers for Medicare and Medicaid Services (CMS) approved various spine surgery codes that neurosurgeons can perform at ACS, this will be contributing further towards the changing patient’s preference towards ambulatory care units over the forecast period.
North America accounted for approximately 55.0% of the market share as of 2017. This is due to the presence of large number of surgical centers and hospitals for cranial surgeries and the demand for technologically advanced surgical devices for neurosurgery. Moreover, rising incidence of brain cancer and high incidence of road accidents in this region are some other factors attributing to its regional market share.
The demand in Asia Pacific region is expected to increase at a lucrative rate due to increasing industrialization that resulted into the incidence of road accidents over the forecast period. Increasing investments by multinational players, government, and other private organizations for developing improved healthcare infrastructure in this region is expected to contribute towards the industry growth in the Asia Pacific region.
The industry is marked by the presence of various small and large medical device manufacturing companies offering products for cranial stabilization and fixation during surgeries. The cranial fixation and stabilization devices market is competitive in nature. It is dominated by major participants such as. Integra LifeSciences Corporation, Stryker, KLS Martin Group, and B. Braun Melsungen AG. The other market participant contributing significantly are Ostomed, Medtronic, and Johnson & Johnson.
Companies are focusing on implementing strategies such as regional expansion, new product developments, partnership agreements, and distribution agreements to increase their revenue share. For instance, in April 2016, Stryker completed the acquisition of Synergetics USA, Inc.'s neuro portfolio in a probe to gain more market share.
Report Attribute |
Details |
Market size value in 2020 |
USD 1.9 billion |
Revenue forecast in 2025 |
USD 2.6 billion |
Growth Rate |
CAGR of 5.6% from 2018 to 2025 |
Base year for estimation |
2017 |
Historical data |
2014 - 2016 |
Forecast period |
2018 - 2025 |
Quantitative units |
Revenue in USD million and CAGR from 2018 to 2025 |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors and trends |
Segments covered |
Product, end use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
The U.S.; Canada; Germany; The U.K.; Japan; China; India; Brazil; Mexico; South Africa |
Key companies profiled |
Integra LifeSciences Corporation; Stryker; KLS Martin Group; B. Braun Melsungen AG |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global cranial fixation and stabilization devices market report on the basis of product, end-use, and region:
Product Outlook (Revenue, USD Million; 2014 - 2025)
Cranial Fixation Devices
Cranial Stabilization Devices
End-use Outlook (Revenue, USD Million; 2014 - 2025)
Hospitals
Ambulatory Surgical Centers
Regional Outlook (Revenue, USD Million; 2014 - 2025)
North America
The U.S.
Canada
Europe
The U.K.
Germany
Asia Pacific
Japan
China
India
Latin America
Brazil
Mexico
Middle East and Africa
South Africa
b. The global cranial fixation and stabilization devices market size was estimated at USD 1.8 billion in 2019 and is expected to reach USD 1.9 billion in 2020.
b. The global cranial fixation and stabilization devices market is expected to grow at a compound annual growth rate of 5.6% from 2018 to 2025 to reach USD 2.6 billion by 2025.
b. North America dominated the cranial fixation and stabilization devices market with a share of 52.7% in 2019. This is attributable to the presence of large number of surgical centers and hospitals for cranial surgeries and demand for technologically advanced surgical devices for neurosurgery.
b. Some of the key players operating in the cranial fixation and stabilization devices market include Integra LifeSciences Corporation, Stryker, KLS Martin Group, and B. Braun Melsungen AG.
b. Key factors that are driving the market growth include rising demand for minimally invasive surgeries, increasing incidence of sports and facial fractures, and technological advancement for the cranial fixation device.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.
We value your investment and offer free customization with every report to fulfil your exact research needs.